I stick with my comment, they can't get the IND, look how long it already took and still nothing on the horizon. Valued close to $200m based on what????? Compare that to the INDs of IMU, RAD and CHM, record speed plus granted at first application every time.
CHM is the other extreme, 4 advanced clinical trials and some outstanding data and the EV at what????
If ALA is valued correctly then All other ASX listed Bio-Techs are way undervalued.
ALA holders are the luckiest the ASX has ever seen, the Hopper-Investors are the most punished ones. 2 people to blame for that, Hopper and the cursed Steini. Not even the combined power of all HC Red Hearts can undo the Steini-curse. Latest crashes caused by Steini: ACW from 9.9c, BDX from 17c, IPD from 24c, RAD from 4.8c, W2V from 3.9c, DVL from 2.7c plus many others.
Stay away from my stocks and pay me not to buy yours.
GLTA
CHM Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)